Affiliation:
1. International Joint
Research Laboratory for Recombinant Pharmaceutical Protein Expression System of Henan, Xinxiang Medical University,
Xinxiang, 453003, China
2. School of Life Science and Technology, Xinxiang Medical University, Xinxiang, 453003, China
Abstract
Abstract:
Breast cancer is the most common cancer affecting women's health and its incidence is increasing. With the development of immunohistochemistry and gene expression microarray technology, the study of breast cancer typing has gradually matured, which has also contributed to the development of targeted therapy for breast cancer. At present, the popular breast cancer cell surface markers include: G protein-coupled estrogen receptor 1 [GPER-1], human epidermal growth factor receptor 2 [HER-2], epidermal growth factor receptor [EGFR], c-mesenchymal-epithelial transition factor [C-Met], folate receptor-α [FRα], integrin, programmed death ligand 1 [PD-L1], trophoblast cell surface antigen 2 [Trop-2], etc. Targeted drugs for breast cancer cell surface markers mainly include antibody drugs and small molecule inhibitor drugs, which exert anti-tumor activity by targeting receptors or ligands. This review summarizes the surface markers of breast cancer cells and their targeted drugs, hoping to provide new ideas for breast cancer targeted therapy.
Funder
Key Scientific Research Project of Colleges and Universities in the Henan Province
Publisher
Bentham Science Publishers Ltd.
Subject
Cell Biology,Molecular Biology,Biochemistry,General Medicine
Reference114 articles.
1. Yan J.; Liu Z.; Du S.; Li J.; Ma L.; Li L.; Diagnosis and treatment of breast cancer in the precision medicine Era. Methods Mol Biol 2020,2204,53-61
2. Akram M.; Iqbal M.; Daniyal M.; Khan A.U.; Awareness and current knowledge of breast cancer. Biol Res 2017,50(1),33
3. McDonald E.S.; Clark A.S.; Tchou J.; Zhang P.; Freedman G.M.; Clinical diagnosis and management of breast cancer. J Nucl Med 2016,57(Suppl. 1),9S-16S
4. Li G.; Hu J.; Hu G.; Biomarker studies in early detection and prognosis of breast cancer. Adv Exp Med Biol 2017,1026,27-39
5. Allarakha A.; Gao Y.; Jiang H.; Wang P.J.; Prediction and prognosis of biologically aggressive breast cancers by the combination of DWI/DCE-MRI and immunohistochemical tumor markers. Discov Med 2019,27(146),7-15
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献